Gitelman
Gitelman syndrome is a rare, inherited renal disorder associated with low levels of potassium and magnesium in the blood, increased levels of calcium in the urine, and elevated blood pH. It is characterized by a variety of symptoms, including muscle weakness, spasms, and cramps, as well as excessive thirst and urination. Gitelman syndrome is caused by mutations in the SLC12A3 gene, which encodes a protein involved in the transport of sodium, potassium, and chloride in the kidney.
Symptoms and signs[edit | edit source]
Gitelman syndrome is typically characterized by a combination of clinical symptoms and biochemical abnormalities. Clinical symptoms can include fatigue, muscle weakness, muscle cramps, and tetany. Biochemical abnormalities can include hypokalemia, hypomagnesemia, hypocalciuria, and metabolic alkalosis.
Genetics[edit | edit source]
Gitelman syndrome is caused by mutations in the SLC12A3 gene, which encodes a protein involved in the transport of sodium, potassium, and chloride in the kidney. This protein is critical for the normal function of the distal convoluted tubule, a part of the kidney involved in the reabsorption of these ions. Mutations in the SLC12A3 gene disrupt this process, leading to the characteristic symptoms and biochemical abnormalities of Gitelman syndrome.
Diagnosis[edit | edit source]
The diagnosis of Gitelman syndrome is typically based on the presence of characteristic clinical symptoms and biochemical abnormalities, as well as genetic testing to identify mutations in the SLC12A3 gene. Additional tests may be performed to rule out other conditions that can cause similar symptoms and biochemical abnormalities, such as Bartter syndrome.
Treatment[edit | edit source]
The treatment of Gitelman syndrome is primarily aimed at correcting the biochemical abnormalities and managing the symptoms. This can involve the use of medications to increase the levels of potassium and magnesium in the blood, as well as measures to manage symptoms such as muscle weakness and cramps.
See also[edit | edit source]
| Gitelman Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
